Exam 61: Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications

A nurse provides teaching to a group of nursing students about the risks and benefits of hormone therapy (HT),including estrogen therapy (ET)and combination estrogen/progestin therapy (EPT). Which statement by a student indicates understanding of the teaching?

A patient with osteopenia asks a nurse about the benefits of hormone therapy in preventing osteoporosis. Which statement by the nurse is correct?

The nurse is providing patient education about the application of transdermal estrogen spray. Which statement made by the patient best demonstrates understanding of the application of this medication? "I should apply this medication to my:

According to studies of estrogen/progestin therapy (EPT),what are its known benefits? (Select all that apply.)

A patient who is at risk for osteoporosis will begin taking the selective estrogen receptor modulator raloxifene [Evista]. Which statement will the nurse include when teaching this patient about the medication?

A postmenopausal patient who has had a hysterectomy and who has a family history of coronary heart disease reports experiencing vaginal dryness and pain with intercourse but tells the nurse that she doesn't want to take hormones because she is afraid of adverse effects. The nurse will suggest that the woman ask her provider about:

The nurse is providing patient education for a postmenopausal patient who is considering EPT. Which risks associated with EPT should the nurse discuss with the patient? (Select all that apply.)

A nurse provides teaching to a patient who has had a hysterectomy and is about to begin hormone therapy to manage menopausal symptoms. Which statement by the patient indicates understanding of the teaching?

A 50-year-old postmenopausal patient who has had a hysterectomy has moderate to severe vasomotor symptoms and is discussing estrogen therapy (ET)with the nurse. The patient is concerned about adverse effects of ET. The nurse will tell her that:

A patient who will begin combination estrogen/progestin therapy (EPT)for menopause asks the nurse why she can't take an estrogen-only preparation. The patient has not had a hysterectomy,has a slightly increased risk of cardiovascular disease,and has mild osteopenia. The nurse will tell her that the progestin is necessary to: